Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 27/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2025-1-4

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and HR (H-Isoniazid, R-Rifampin) treatment group.

Abundance in Group 1: increased abundance in HR (H-Isoniazid, R-Rifampin)

NCBI	Quality Control	Links
Acetatifactor
Akkermansia
Alistipes
Anaeroplasma
Anaerosporobacter
Anaerostipes
Arthrobacter
Bacteroides
Blautia
Coprobacter
Dysgonomonas
Enterorhabdus
Erysipelothrix
Erysipelotrichaceae
Eubacterium
Intestinimonas
Lachnospiraceae
Mucispirillum
Oscillibacter
Pseudoflavonifractor
Roseburia
Tannerella
Thomasclavelia

Revision editor(s): KateRasheed